RUNX1 Familial Platelet Disorder Clinical Trials in Houston, Texas

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder